Nano-Pharmacokinetics and Theranostics: Advancing Cancer Therapy

Authored by Nanasaheb D. Thorat, this comprehensive guide delves into the translational aspects and clinical perspectives of nano-pharmacokinetics, using cancer as a model disease. It explores the emerging sub-discipline of nanoscience and medical sciences, focusing on the dynamics of nanosystems in living organisms to better understand nanotoxicity, pharmacology, biochemistry, physiology, and medicine perspectives.

The book is divided into three sections. The first section introduces the concept of pharmacokinetics with state-of-the-art Nano-Pharmacokinetics (NPK). The second section discusses the engineering of nanoparticles and pharmacokinetics clinical development. The final section delves into Nano-Pharmacokinetics and Theranostics, examining how the pharmacokinetics of nanomaterials relate to their end applications, such as cancer therapy.

Nano-Pharmacokinetics and Theranostics: Advancing Cancer Therapy is an invaluable resource for researchers in the field of nanoparticle-based targeted drug delivery, including pharmaceutical scientists, material scientists, chemists, nanotechnologists, biomedical scientists, and clinicians. It includes contributions from highly qualified scientists, regulatory entities, enterprises, and medical practitioners to explain the multidisciplinary pathway of nano-pharmacokinetics.

This book describes assessment methods of nano-pharmacokinetics and examines the interface between nanomedicine and pharmacokinetics to diagnose and treat cancer. It provides a comprehensive understanding of the long and inherently multidisciplinary pathway of nano-pharmacokinetics, making it a must-have for anyone involved in the development of nanoparticle-based therapies.

Published by Elsevier Science on July 28, 2021, this book is available in English. The ISBNs are 9780323850506 and 9780323859820. It is a vital addition to any library focusing on nanoscience, medical sciences, and cancer research.